Girish Malhotra, EPCOT International06.02.15
Traditions, their preservation and change, are part of human heritage. They provide comfort until a “creative destructionist” comes along and tips over the apple cart. A recent Wall Street Journal article1 mentions “continuous processing” as a way to bring about change to pharmaceutical manufacturing. The benefits are enormous but we have to concede that we will need to rethink and modify the current business model, operating philosophies, process equipment and regulations. Changes will be needed to the current landscape and that may not be easy.
The application and adoption of different manufacturing technologies and operating philosophies is an uphill task in pharmaceuticals. Active pharmaceutical ingredients (APIs) can be formulated continuously but as discussed later will require additional work to suit the dose and demand needs. Selective application of continuous API manufacturing is definitely possible.2, 3, 4, 5
This article reviews the business and process considerations for continuous processes. They are very different for the manufacture of APIs and their formulations. Any and every improve
The application and adoption of different manufacturing technologies and operating philosophies is an uphill task in pharmaceuticals. Active pharmaceutical ingredients (APIs) can be formulated continuously but as discussed later will require additional work to suit the dose and demand needs. Selective application of continuous API manufacturing is definitely possible.2, 3, 4, 5
This article reviews the business and process considerations for continuous processes. They are very different for the manufacture of APIs and their formulations. Any and every improve
Continue reading this story and get 24/7 access to Contract Pharma for FREE
FREE SUBSCRIPTION
